Literature DB >> 22214902

Magnetic resonance imaging reveals slow-down of global cerebral oxygen metabolism in multiple sclerosis.

Risto A Kauppinen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22214902      PMCID： PMC3293126          DOI： 10.1038/jcbfm.2011.192

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN： 0271-678X            Impact factor:   6.200


× No keyword cloud information.
  10 in total

1.  Determination of oxygen extraction ratios by magnetic resonance imaging.

Authors:  J M Oja; J S Gillen; R A Kauppinen; M Kraut; P C van Zijl
Journal:  J Cereb Blood Flow Metab       Date:  1999-12       Impact factor: 6.200

Review 2.  Imaging biomarkers in multiple sclerosis.

Authors:  M Filippi; F Agosta
Journal:  J Magn Reson Imaging       Date:  2010-04       Impact factor: 4.813

3.  Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T.

Authors:  Jason M Zhao; Chekesha S Clingman; M Johanna Närväinen; Risto A Kauppinen; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2007-09       Impact factor: 4.668

4.  Combined (1)H and (31)P spectroscopy provides new insights into the pathobiochemistry of brain damage in multiple sclerosis.

Authors:  Elke Hattingen; Jörg Magerkurth; Ulrich Pilatus; Annemarie Hübers; Mathias Wahl; Ulf Ziemann
Journal:  NMR Biomed       Date:  2010-12-12       Impact factor: 4.044

Review 5.  Energy failure in multiple sclerosis and its investigation using MR techniques.

Authors:  David Paling; Xavier Golay; Claudia Wheeler-Kingshott; Raju Kapoor; David Miller
Journal:  J Neurol       Date:  2011-06-10       Impact factor: 4.849

6.  Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis.

Authors:  D J Brooks; K L Leenders; G Head; J Marshall; N J Legg; T Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

7.  Characterizing brain oxygen metabolism in patients with multiple sclerosis with T2-relaxation-under-spin-tagging MRI.

Authors:  Yulin Ge; Zhongwei Zhang; Hanzhang Lu; Lin Tang; Hina Jaggi; Joseph Herbert; James S Babb; Henry Rusinek; Robert I Grossman
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-18       Impact factor: 6.200

8.  Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis.

Authors:  Matilde Inglese; Sumita Adhya; Glyn Johnson; James S Babb; Laura Miles; Hina Jaggi; Joseph Herbert; Robert I Grossman
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-02       Impact factor: 6.200

Review 9.  Disease-modifying agents for multiple sclerosis: recent advances and future prospects.

Authors:  Til Menge; Martin S Weber; Bernhard Hemmer; Bernd C Kieseier; Hans-Christian von Büdingen; Clemens Warnke; Scott S Zamvil; Aaron Boster; Omar Khan; Hans-Peter Hartung; Olaf Stüve
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Systematic review of genome-wide expression studies in multiple sclerosis.

Authors:  A K Kemppinen; J Kaprio; A Palotie; J Saarela
Journal:  BMJ Open       Date:  2011-07-18       Impact factor: 2.692
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.